Founded in 1887, NIH is the federal focal point for health research in the United States. Today, it is one of the agencies in the Department of Health and Human Services. Its mission is science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability. NIH works toward meeting the mission by providing leadership, direction, and grant support to programs designed to improve the health of the nation through research.
NIH’s education programs contribute to ensuring the continued supply of well-trained basic research and clinical investigators, as well as the myriad professionals in many allied disciplines who support the research enterprise. These efforts also help educate people about scientific results so that they can make informed decisions about their own—and the public’s—health.
This curriculum supplement is one such education effort. It is a collaboration among the Office of Rare Diseases Research, the NIH Office of Science Education, and Biological Sciences Curriculum Study.
For more about NIH, visit http://www.nih.gov.
The Office of Rare Diseases (ORD) was established in 1993 at the National Institutes of Health. Later, the ORD’s focus on research prompted a name change to the Office of Rare Diseases Research (ORDR). The ORDR provides information on rare diseases and rare disease research; supports scientific conferences; cosponsors, with the National Human Genome Research Institute, the Genetic and Rare Diseases Information Center; and coordinates and supports research on the diagnosis and treatment of rare diseases both intramurally and extramurally. The Office also funds the Rare Diseases Clinical Research Network (RDCRN), a group of clinical research sites in the United States and several foreign countries working on about 100 different rare diseases, and is working to harmonize community efforts on patient registries and biospecimen repositories. A rare disease (also called an “orphan disease”) is a condition affecting fewer than 200,000 people in the United States (about 1 in 1,500) or one affecting more people but “for which no reasonable expectation exists that the costs of developing or distributing a drug can be recovered from the sale of the drug in the United States” (Orphan Drug Act of 1983).
For more about the ORDR, visit http://rarediseases.info.nih.gov.
Headquartered in Colorado Springs, Colorado, BSCS was founded in 1958 as a curriculum study committed to an evidence- and inquiry-based approach to science education. BSCS instructional materials and professional development services are based on current research about teaching and learning for all science classrooms, kindergarten through college.
BSCS’s materials are extensively field-tested in diverse settings across the country and evaluated for proven effectiveness. The BSCS 5E Instructional Model and inquiry are hallmarks of its materials, placing students at the center of their learning.
The BSCS mission is to transform science teaching and learning through research and development that strengthens learning environments and inspires a global community of scientifically literate citizens. BSCS is a 501(c)(3) nonprofit organization.
For more information, please visit http://www.bscs.org.